Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for mycosis fungoides variant.
2 publications have been identified in PubMed for mycosis fungoides variant. Research spans Basic Science / Preclinical (50%) and Epidemiology / Natural History (50%).
Halwag DI (2025). [PMID: 40401875](https://pubmed.ncbi.nlm.nih.gov/40401875/). *Dermatol Pract Concept*. [Epidemiology / Natural History]
Shrestha S (2024). [PMID: 39298006](https://pubmed.ncbi.nlm.nih.gov/39298006/). *J Hematop*. [Basic Science / Preclinical]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 6:57 PM UTC
AI-curated news mentioning mycosis fungoides variant
Updated Aug 26, 2026
Recent research highlights oral mycosis fungoides, a rare form of cutaneous T-cell lymphoma affecting the oral cavity. This study contributes to the understanding of its clinical presentation and management.
A recent study highlights the psychological distress and symptom burden faced by patients with mycosis fungoides and Sézary syndrome, impacting their overall quality of life. This research underscores the need for comprehensive care strategies addressing both physical and mental health in these patients.
A retrospective cohort study evaluates the prognostic value of skin lesion characteristics in subcutaneous panniculitis-like T-cell lymphoma. The research assesses the applicability of the T category of the TNM classification for primary cutaneous lymphomas, excluding mycosis fungoides and Sézary syndrome.